NSAIDS Flashcards
NSAIDs Funtion?
Treat inflammation, pain & fever
NSAIDS MOA?
Inhibition of the enzyme cyclooxygenase (COX).
Cyclooxygenase is required to convert arachidonic acid into thromboxanes, prostaglandins, and prostacyclins.[9] The therapeutic effects of NSAIDs are attributed to the lack of these eicosanoids.
↓ production of prostaglandins → ↓inflammation, relieve pain,
↓fever
Inflammation process?
- Membrane Phospholipids.
- Phospholipase A2
- Arachnoic Acid
- Cyclooxygenase(COX)
- COX 1 & COX 2
COX-1 Function
- Increase GIT integrity/mucous lining(PGE2)
2.Promotes pain, inflammation and pain - Thromboxane(TXA2)-promotes clotting aggregation and thus increase in bleeding time
COX-1 Inhibition
Peptic Ulcers and GI Bleeding
COX-2 Function?
- Promote pain, fever and inflammation
- Increased in synovial fluid
- Reduces platelet aggregation
COX and prostaglandins ?
COX-1: Prostaglandins E29(PGE2)
COX-2:Prostacyclin(PGI2)
Classes of NSAIDs?
- Irreversible COX inhibitors (Aspirin)
- Reversible COX inhibitors (non‐aspirin NSAIDs):
A) Non‐selective COX inhibitors (e.g. Ibuprofen)
B) Selective COX‐2 inhibitors (e.g. Celecoxib)
Irreversible COX inhibitors drug?
Aspirin(acetylsalicylic acid; ASA)
Aspirin MOA?
*Irreversible inhibitor of COX‐1 & COX‐2
-Higher afffinity fro COX-1
*Taken orally
Aspirin MOA antiplatlet?
MOA (antiplatelet): (‐) COX‐1 in platelets → ↓producƟon of thromboxane
A2 (platelet acƟvator) → (‐) platelet production of new COX‐1; new
platelets → COX‐1 enzymes → ↑bleeding Ɵme (w/o affecting PT)
Aspirin is non-selective fro COX but which Cox does it have a higher affinity for?
COX-1
Aspirin MOA anti-inflammatory MOA?
MOA (anti‐inflammatory): in liver; metabolised into salicylate (anti‐
inflammatory; no antiplatelet effect); (‐) COX‐2 →↓prostaglandin
producƟon → ↓inflammaƟon, pain, fever.
Aspirin I?
I: headaches, musculoskeletal pain; short term Tx of chronic pain (e.g.
osteoarthritis, rheumatoid arthritis)
Aspirin Doses and effects?
Dose‐dependent effects
Low doses: antiplatelet effect
High doses: Dose‐dependent effects (<300 mg/day, antiplatelet; 300‐2400 mg/day,
antipyretic & analgesic; >2400 mg/day, anti‐inflammatory) & analgesic; >2400 mg/day, anti‐inflammatory)
Aspirin CI?
aspirin‐associated hypersensitivity
bleeding GI ulcers
hemolytic
anemia
hemophilia
hemorrhoids,
Lactation
UC
asthma
chronic diarrhea
Aspirin AE?
ASPIRIN
Allergy like reactions
Susceptibility to bleeding
Peptic Ulcer
Idiosyncratic reactions
Reye’s Syndrome
rIing in ear(Tinititus)
Nephtopathy
NSAIDS CI?
BARS
Bleeding
Asthma
Renal Disease
Stomach(Peptic Ulcer)
Aspirin Kinetics?
M&E
Kinetics: A=80‐100%
D=90‐95% protein‐bound
M=liver
E=urine (80‐100%), sweat, saliva, feces
Effects of Inhibtion of NSAIDS?
5A’s
Analgesia
Antipyretic
Anti-inflammatory
Antithrombotic
Arteriosis
Non-selective COX-Inhibitors?
Reversible COX inhibitors admin?
Orally
Which Reversible COX inhibitors is taken rectaly?
indomethacin
Which Reversible COX inhibitors is taken as eye-drops only?
ketorolac(eye drops), phenazone(ear drops only)
Non‐selective COX inhibitors:
MOA?
Reversibly (‐) COX‐1 (→ ↓producƟon of thromboxane A2 → (‐)
platelet aggregation; transient) & COX‐2 (→↓prostaglandin producƟon →
↓inflammaƟon, pain, fever)
Ibuprofen I?
Analgesia, inflammation (high dose required for anti‐inflammatory
action), ductus arteriosus in premature new‐born infants (IV prep.)
Ibuprofen CI?
hypersensitivity to aspirin/other NSAIDs active peptic ulceration
pregnancy (3rd trim.)
proctitis/haemorrhoids (suppositories)
Ibuprofen AE?
epigastric pain, heartburn, dizziness, nausea, rash, tinnitus
Ibuprofen Kinetics?
A, D, M & E
Kinetics:
A=rapid (85%) reduced by food; bioav. 80‐100%; onset30‐60
min; duration4‐6 hr
D=90‐99% protein‐bound
M=rapidly in liver by
CYP2C9; CYP2C19 substrate, E= t 1/22‐4 hr (adults); 1.6 hr (child 0.25‐1 yr)
Naproxen I?
Analgesia & inflammation in rheumatic disease, gout, dysmenorrhea
Analgesia?
Antipyretic?
Anti-inflammatory?
Antithrombotic?
Arteriosus?
Analgesia: Inability to feel pain
Antipyretic: used to prevent or reduce fever
Anti-inflammatory: used to prevent inflammation
Arteriosus:
Naproxen CI?
hypersensitivity to aspirin/other NSAIDs, active peptic ulceration,
pregnancy (3rd trim.), proctitis/haemorrhoids
Naproxen A/E?
epigastric pain, peptic ulceration, headache, dizziness, rash, tinnitus,
nephrotoxicity, hepatic dysfunction
Naproxen kinetics?
M, D & E
A= rapid oral; bioav. 95%; onset30‐60 min; duration<12 hr,
D=99% protein‐bound
M=in liver via conjugation
E= t 1/212‐15 hr; 95% in
urine as metabolites
Diclofenac I?
pain & inflammation in rheumatic disease, gout
Diclofenac CI?
hypersensitivity to aspirin/other NSAIDs, active peptic ulceration,
pregnancy (3rd trim.), proctitis/haemorrhoids (suppositories)
Diclofenac A/E?
epigastric pain, peptic ulceration, headache, dizziness, rash, tinnitus,
nephrotoxicity, hepatic dysfunction
Diclofenac Kinetics?
A, D, M & E
A=absolute bioav. 55%
D=diffuses into/out of synovial fluid; 99%
protein‐bound
M=in liver via glucuronidation
E= t 1/212‐15 hr; in bile
Indomethacin I?
pain & inflammation in rheumatological disorders
Indomethacin CI?
hypersensitivity to aspirin/other NSAIDs, active peptic ulceration,
pregnancy (3rd trim.), proctitis/haemorrhoids (suppositories)
Indomethacin A/E?
as for diclofenac (more than diclofenac on GI), dizziness, drowsiness,
headaches, retinal disturbances (prolonged use)
Indomethacin Kinetics?
A, D, M & E
A= bioav. 100%; onset30 min; duration4‐6 hr
D=99% protein‐bound
M=in liver
E= t 1/24.5 hr; 60% in urine; >33% in feces
Ketorolac I?
short‐term management of moderate postoperative pain
Ketorolac CI?
duration >5 days, chronic pain, hypersensitivity to NSAIDs, PUD
Ketorolac A/E?
dizziness, drowsiness, headaches, GI pain, nausea, dyspepsia,
somnolence
Ketorolac Kinetics?
A= bioav. 80‐100%; onset10 min IM, 30‐60 min PO; duration4‐6 hr
D=99% protein‐bound
M=in liver, E= t 1/22‐6 hr; dialysable; 91% in urine; 6% in feces
Lornoxicam I?
short‐term treatment of mild to moderate pain, osteoarthritis,
rheumatoid arthritis
Lornoxicam CI?
GI bleeding, coagulation disorders, children <18 yrs, known
hypersensitivity to NSAIDs, active peptic ulceration
Lornoxicam A/E?
dizziness, insomnia, migraines, gastritis, N&V, dyspepsia, somnolence,
gastro‐esophageal reflux
Lornoxicam Kinetics?
E= t 1/23‐4 hr
Meloxicam I?
painful osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute
sciatica
Meloxicam CI?
GI bleeding/perforation/ulceration, IBD, heart failure, known
hypersensitivity to NSAIDs
Meloxicam A/E?
light‐headedness, dizziness, insomnia, headache, gastritis,
bronchospasm, rash, renal failure
Maloxicam kinetics?
E= t 1/220 hr
Piroxicam I?
rheumatic disorders, acute musculoskeletal disorders, acute gout,
dysmenorrhea
Piroxicam CI?
GI bleeding/perforation/ulceration, IBD, heart failure, known
hypersensitivity to NSAIDs
Piroxicam A/E?
light‐headedness, dizziness, insomnia, headache, gastritis,
bronchospasm, rash, renal failure
Piroxicam Kinetics?
E= t 1/250 hr
Mefenamic acid I?
post‐traumatic conditions, dysmenorrhea
Mefenamic acid CI?
GI bleeding/perforation/ulceration, IBD, heart failure, known
hypersensitivity to NSAIDs
Mefenamic acid A/E?
light‐headedness, dizziness, insomnia, headache, gastritis,
bronchospasm, rash, renal failure
Mefanamic Kinetics
A= bioav. Extensiveonsetrapid, D=↑protein‐bound
M=in liver via oxidation/conjugation
E= t 1/22 hr; dialysable; 66% urine; 20‐25% feces
Reversible COX inhibitors?
Selective COX‐2 inhibitors
Selective COX‐2 inhibitors?
Celecoxib
etoricoxib
parecoxib
meloxicam
Selective COX‐2 inhibitors MOA?
selectively (‐) COX‐2 → ↓prostaglandins synthesis → ↓pain +
inflammation
Selective COX‐2 inhibitors decreases risk of what?
↓risk of pepƟc ulceraƟon; ↓risk of renal failure (or other AE of
NSAIDs); ↑risk of heart aƩacks, strokes and thrombosis by a relaƟve ↑
in thromboxane
Celecoxib I?
symptomatic treatment of inflammation & pain in osteoarthritis and rheumatoid arthritis; pain after dental surgery
Celecoxib CI?
hypersensitivity to sulphonamides, severe renal/hepatic impairment,
asthma, allergy to NSAIDs, risk to cardiovascular disease, pregnancy
Celecoxib A/E?
dyspepsia, abd. pain, diarrhea, N&V, flatulence, SJS
Celecoxib Kinetics?
A= bioav. undetermined
D=97% protein‐bound
M=in liver via CYP2C9
E= t 1/211 hr; inactive metabolites in urine and feces
Etoricoxib I?
osteoarthritis, rheumatoid arthritis, gouty arthritis, primary
dysmenorrhea
Etoricoxib CI?
hypersensitivity to sulphonamides, severe renal/hepatic impairment,
asthma, allergy to NSAIDs, risk to cardiovascular disease, pregnancy
Etrocicoxib kinetics?
A= bioav. undetermined
D=97% protein‐bound
M=in liver via CYP2C9
E= t 1/211 hr; inactive metabolites in urine and feces
Etoricoxib I?
osteoarthritis, rheumatoid arthritis, gouty arthritis, primary
dysmenorrhea
AE:dizziness, headache, palpitations, bronchospasm, gastritis, SJS, tinnitus
Etoricoxib CI?
hypersensitivity to sulphonamides, severe renal/hepatic impairment,
asthma, allergy to NSAIDs, risk to cardiovascular disease, pregnancy
Etoricoxib A/E?
AE:dizziness, headache, palpitations, bronchospasm, gastritis, SJS, tinnitus
Parecoxib I?
I: preoperative pain
COX-1 Inhibits what?
Decreases production of thromboxane
COX-2 decreases production of PGs
COX-2 decreases production of PGs
Names of common NSAIDS?
CAIN Caused pain lol
Celebrax
Aspirin
Indomethicin/Ibuprofen
Naproxen
Names od common NSAIDS?
NSAIDS
Naproxen
Salicylate
Advil
Ibuprofen/Indomethicin
Diclofenac
Sulindac
Reversible COX-Inhibitions self-separation to distinguish CI?
DIN
CI: Hypersensitivity to aspirin, active peptic ulceration, pregnancy, proctitis
LMPM
CI: GI bleeding, perforation, ulceration, IBD, Heart failure, known hypersensitivity to NSAIDS
Ketorolac
CI: Duration >5days, chronic painii, hypersensitivity to NSAIDS, PUD